Major Market Shift in Autism Spectrum Disorder Diagnostics Industry: Innovative Technologies And Tools Enhance Early Detection And Diagnosis

What Is the Forecasted Market Size and Growth Rate for the Autism Spectrum Disorder Diagnostics Market?
The market size for diagnostics related to autism spectrum disorder has seen considerable growth in recent years. The market, valued at $27.39 billion in 2024, is predicted to swell to $29.44 billion in 2025, illustrating a compound annual growth rate (CAGR) of 7.5%. The significant growth seen during the historic period can be credited to factors such as an increase in public understanding of ASD, expansion in diagnostic criteria, advancements in diagnostic equipment, enhancements in healthcare systems, and public health campaigns.

The market size for diagnosing autism spectrum disorder is predicted to experience robust expansion in the coming years, projecting a rise to a $38.94 billion valuation by 2029 with a compound annual growth rate (CAGR) of 7.2%. Various factors such as the mounting prevalence of autism spectrum disorder, the acceleration of awareness and early detection initiatives, and the emphasis on precision medicine and biomarkers contribute to this growth during the forecast period. Major trends in this timeframe encompass the ongoing development of cutting-edge technologies, growing focus on diagnosis in adults, surging demand for point-of-care testing, inclusion of artificial intelligence (AI) and machine learning, and a rise in research activities.

What Are the Key Drivers Behind the Growth of the Autism Spectrum Disorder Diagnostics Market?
The expansion of specialized diagnostic centers is predicted to fuel the growth of the diagnostic market for autism spectrum disorders. A center that specializes in autism diagnosis houses healthcare professionals, psychologists, and experts who carry out extensive evaluations for the diagnosis of autism spectrum disorder. The rise in such centers is attributed to advancements in diagnostics, the call for comprehensive care, professional education, research, and acknowledgment of autism as a health matter of public importance. These specialized diagnostic centers are crucial in boosting diagnostic precision, expediting early intervention, and improving the end-result for those diagnosed with ASD, by providing specialist expertise, cutting-edge diagnostic devices, comprehensive assessments, custom treatment plans, family assistance, and chances for research partnerships. For example, Autism Speaks, an American non-profit autism awareness organization, reported an increase in autism care network sites from 20 to 25 within North America from 2021 to 2022. Consequently, the surge in specialized diagnostic centers is bolstering the growth of the diagnostic market for autism spectrum disorders.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp

Which Businesses Are at the Forefront of Autism Spectrum Disorder Diagnostics Market Development?
Major companies operating in the autism spectrum disorder diagnostics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Siemens Healthineers, Quest Diagnostics Incorporated, Agilent Technologies Inc., Otsuka Pharmaceutical Co. Ltd., ARUP Laboratories, Invitae Corporation, Ambry Genetics, Cortica Inc., GeneDx, Cognoa Inc., Axial Therapeutics Inc., Curemark, EarliTec Diagnostics Inc., Yamo Pharmaceuticals

What Are the Latest Innovations in the Autism Spectrum Disorder Diagnostics Market?
Leading businesses in the autism spectrum disorder diagnostics market are pushing the envelope with advanced solutions such as Dynamic Quantification of Social-Visual Engagement (DQSVE) utilising devices for a competitive edge. These gadgets record and examine a child's eye movements in real time, around 120 times per second. For example, Marcus Autism Center, a nonprofit healthcare and research organization from the US, in September 2023, rolled out the EarliPoint™ Evaluation. This revolutionary FDA-approved device is specifically designed for early detection of autism spectrum disorder in children aged between 16 to 30 months. By employing eye-tracking technology, it assess children's social behaviours, cutting down the diagnostic time from hours to roughly 12 minutes.

How Is the Autism Spectrum Disorder Diagnostics Market Segmented?
The autism spectrum disorder diagnostics market covered in this report is segmented -

1) By Type: Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types
2) By Service: Behavioral Approaches, Early Intervention, Medication, Other Services
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Autistic Disorder: Classic Autism, Severe Autism, Mild Autism
2) By Asperger Syndrome: High Functioning Asperger Syndrome, Low Functioning Asperger Syndrome
3) By Pervasive Developmental Disorder (PDD): PDD-NOS, Childhood Disintegrative Disorder: Rett Syndrome
4) By Other Types: Childhood Autism Spectrum Disorder, Atypical Autism, Other Related Developmental Disorders

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

Where Is the Autism Spectrum Disorder Diagnostics Market Growth Most Prominent?
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2024. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Autism Spectrum Disorder Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Autism Spectrum Disorder Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Autism Spectrum Disorder Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Autism Spectrum Disorder Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Autism Spectrum Disorder Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16593

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.